Samuel Weisbrod

USPTO Granted Patents = 6 (Patent Applications = 15)

CIPO Patents = 3 (Patent Applications = 15)

EPO Patents = 3 (Patent Applications = 16)

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 6(Granted Patents)

Company Filing History:

Ascendis Pharma Ophthalmology Division A/s

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12246070 - Hydrogel cross-linked hyaluronic acid prodrug compositions and methods (2025-03-11),

2. 11896671 - Conjugation method for carrier-linked prodrugs (2024-02-13),

3. 11642415 - Hydrogel cross-linked hyaluronic acid prodrug compositions and methods (2023-05-09),

4. 11298427 - Prodrugs comprising a pyroglutamate linker (2022-04-12),

5. 10519226 - VEGF neutralizing prodrugs for the treatment of ocular conditions (2019-12-31),

6. 10040850 - Protecting group comprising a purification tag (2018-08-07),

Title: Samuel Weisbrod - Innovative Inventor from Heidelberg

Introduction: Samuel Weisbrod is a renowned inventor hailing from Heidelberg, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Samuel Weisbrod holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Samuel Weisbrod has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation and creating solutions to complex problems.

Collaborations: Throughout his career, Samuel Weisbrod has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Samuel Weisbrod's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the global tech community.

This text is generated by artificial intelligence and may not be accurate.